In this article, we showed that FGFR1 is amplified in lung cancer, breast cancer and, rarely, in pancreatic cancer and squamous cell cancer, whereas FGFR2 amplification mainly occurs in gastric cancer and breast cancer. The gene discussed is FGFR1; the disease is breast carcinoma.